Unregistered User If this is not your name, click here.
		Contact Us | Order Now | Journals | Bookstore | Register a colleague
	Select a ChannelAcneAIDS and HIVAllergy OtherAlzheimer'sAnaesthesiology OtherAngina Pectoris/MIAnxietyArthritis OtherAsthmaBack PainBacterial InfectionsBladder CancerBone Marrow TransplantationBreast CancerCardiology OtherCataractCell TransplantationCervical CancerCholesterol/Lipid disordersCirrhosisClinical PharmacologyColorectal CancerCongestive Heart FailureContact DermatitisContraceptionCOPDCystic FibrosisDental and Oral DisordersDepressionDermatology OtherDiabetesDialysisEating DisordersElbowEmergency MedicineEndocrinology OtherEpilepsyErectile DysfunctionFibromyalgiaGastro OtherGeneticsGenitourinary OtherGeriatricsGERD/GastritisGlaucomaH. Pylori/UlcerHaematology OtherHair LossHeadachesHepa/Biliary OtherHepatitisHipHRTHypertensionIBDImmunologyInfectious OtherInfertilityIntensive CareIrritable Bowel SyndromeKneeLeukemiasLiver CancerLung CancerLupusLymphomasMelanomaMenopauseMultiple Sclerosis Nephrology OtherNeurologic OtherNutritional / Metabolic OtherOb/Gyn OtherObesityOncology OtherOphth. OtherOphthalmic SurgeryOrgan TransplantationOrthopaedics OtherOsteoarthritisOsteoporosisOtitisOtorhino. OtherOvarian CancerPaediatricsPainPancreatic CancerParkinson'sPregnancyProstate CancerPsychiatry OtherPulmonary OtherRadiologyRenal CancerRenal FailureRespiratory InfectionsRheumatoid arthritisRheumatology OtherRhinitisSchizophreniaShoulderSleep ApnoeaSleep DisordersSpineStrokeSTDsSurgeryThyroid DisordersTransfusionTransplant Surgery OtherTraumaUrinary IncontinenceUrinary tract infectionsVaccinologyVascular DisordersViral Infections

SEARCH   News Bookstore Medline The Web Meetings & Congresses Complete Doctor's Guide    EXPLORE :    All News   All Webcasts   All Cases   All Meetings & Congresses   All Medical Resources New drugs / indications English Dictionary Medical Dictionary Thesaurus Warning | Privacy | Awards  Favourite Journals  Click here to choose your favourite journals  Favourite Sites  Click here to choose your favourite sites  Languages  Select languageEnglishFrançais

FDA Approves Bepotastine Besilate Solution for Ocular Itching Associated With Allergies NEW YORK -- September 9, 2009 -- The US Food and Drug Administration (FDA) has approved bepotastine besilate ophthalmic solution (Bepreve) 1.5% as a twice-daily prescription eye drop treatment for ocular itching associated with allergic conjunctivitis in patients aged 2 years and older. The approval is based on 2 phase 3, double-masked, placebo-controlled, conjunctival allergen challenge (CAC) studies which demonstrated that bepotastine besilate solution significantly reduced ocular itching. In addition, the studies achieved statistical significance and demonstrated bepotastine besilate ophthalmic solution’s rapid onset of action in providing relief to persons with ocular itching associated with allergic conjunctivitis. “Patients who experience ocular itching due to allergies want comfortable, quick and long-lasting relief for their eyes,” said Gregg J. Berdy, MD, Clinical Ophthalmology, Washington University School of Medicine, St. Louis, Missouri. “[Bepotastine besilate solution] is the first truly new treatment for allergic conjunctivitis approved in several years…” commented Gregg J. Berdy, M.D., Assistant Professor of Clinical Ophthalmology, Washington University School of Medicine. The most common reported adverse reaction occurring in approximately 25% of patients was a mild taste following instillation. Other adverse reactions occurring in 2% to 5% of patients were eye irritation, headache, and nasopharyngitis. SOURCE: ISTA Pharmaceuticals E-mail this page to a friend or colleague! To print, use this version